Submitted by Anonymous (not verified) on 11 September 2023 - 14:26
Human medicines European public assessment report (EPAR): Abiraterone Mylan, abiraterone acetate, Prostatic Neoplasms, Date of authorisation: 20/08/2021, Revision: 4, Status: Authorised
Source: